Literature DB >> 11281080

Ophthaproblem. Herpes zoster.

S Baxter1, S Sharma.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11281080      PMCID： PMC2018397     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  9 in total

Review 1.  NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention.

Authors:  S E Straus; J M Ostrove; G Inchauspé; J M Felser; A Freifeld; K D Croen; M H Sawyer
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

2.  Complications of herpes zoster ophthalmicus.

Authors:  L W Womack; T J Liesegang
Journal:  Arch Ophthalmol       Date:  1983-01

3.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

4.  Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.

Authors:  J Colin; O Prisant; B Cochener; O Lescale; B Rolland; T Hoang-Xuan
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

5.  Racial differences in the occurrence of herpes zoster.

Authors:  K Schmader; L K George; B M Burchett; C F Pieper; J D Hamilton
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

6.  Prednisolone does not prevent post-herpetic neuralgia.

Authors:  V Esmann; J P Geil; S Kroon; H Fogh; N A Peterslund; C S Petersen; J O Ronne-Rasmussen; L Danielsen
Journal:  Lancet       Date:  1987-07-18       Impact factor: 79.321

7.  Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement.

Authors:  S P Harding; J R Lipton; J C Wells
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

8.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

9.  Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus.

Authors:  C Neoh; S P Harding; D Saunders; S Wallis; A B Tullo; A Nylander; M E Nelson
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.